BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vallianou N, Stratigou T, Christodoulatos GS, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives. Curr Obes Rep. 2019;8:317-332. [PMID: 31175629 DOI: 10.1007/s13679-019-00352-2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 35.5] [Reference Citation Analysis]
Number Citing Articles
1 Spyrou N, Vallianou N, Kadillari J, Dalamaga M. The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era. Seminars in Cancer Biology 2021;73:356-76. [DOI: 10.1016/j.semcancer.2021.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Moreno-Navarrete JM, Fernandez-Real JM. The gut microbiota modulates both browning of white adipose tissue and the activity of brown adipose tissue. Rev Endocr Metab Disord 2019;20:387-97. [PMID: 31776853 DOI: 10.1007/s11154-019-09523-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
3 Green M, Arora K, Prakash S. Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome. Int J Mol Sci 2020;21:E2890. [PMID: 32326175 DOI: 10.3390/ijms21082890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
4 Lee S, Knotts TA, Goodson ML, Barboza M, Wudeck E, England G, Raybould HE. Metabolic Responses to Butyrate Supplementation in LF- and HF-Fed Mice Are Cohort-Dependent and Associated with Changes in Composition and Function of the Gut Microbiota. Nutrients 2020;12:E3524. [PMID: 33207675 DOI: 10.3390/nu12113524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nugent JL, Singh A, Wirth KM, Oppler SH, Hocum Stone L, Janecek JL, Sheka AC, Kizy S, Moore MEG, Staley C, Hering BJ, Ramachandran S, Ikramuddin S, Graham ML. A nonhuman primate model of vertical sleeve gastrectomy facilitates mechanistic and translational research in human obesity. iScience 2021;24:103421. [PMID: 34877488 DOI: 10.1016/j.isci.2021.103421] [Reference Citation Analysis]
6 Dallas JW, Warne RW. Captivity and Animal Microbiomes: Potential Roles of Microbiota for Influencing Animal Conservation. Microb Ecol 2022. [PMID: 35316343 DOI: 10.1007/s00248-022-01991-0] [Reference Citation Analysis]
7 Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, Hanif A, Li W, Guo X. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. Int J Biol Sci 2021;17:818-33. [PMID: 33767591 DOI: 10.7150/ijbs.56214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yang M, Yin Y, Wang F, Zhang H, Ma X, Yin Y, Tan B, Chen J. Supplementation With Lycium barbarum Polysaccharides Reduce Obesity in High-Fat Diet-Fed Mice by Modulation of Gut Microbiota. Front Microbiol 2021;12:719967. [PMID: 34512598 DOI: 10.3389/fmicb.2021.719967] [Reference Citation Analysis]
9 Hijová E. Synbiotic Supplements in the Prevention of Obesity and Obesity-Related Diseases. Metabolites 2022;12:313. [DOI: 10.3390/metabo12040313] [Reference Citation Analysis]
10 Gawlik-Kotelnicka O, Skowrońska A, Margulska A, Czarnecka-Chrebelska KH, Łoniewski I, Skonieczna-Żydecka K, Strzelecki D. The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation, and Oxidative Stress Parameters and Fecal Microbiota in Patients with Depression Depending on Metabolic Syndrome Comorbidity-PRO-DEMET Randomized Study Protocol. J Clin Med 2021;10:1342. [PMID: 33804999 DOI: 10.3390/jcm10071342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Croci S, D'Apolito LI, Gasperi V, Catani MV, Savini I. Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites. Nutrients 2021;13:1389. [PMID: 33919016 DOI: 10.3390/nu13051389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen HT, Huang HL, Li YQ, Xu HM, Zhou YJ. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World J Gastroenterol 2020; 26(16): 1901-1911 [PMID: 32390701 DOI: 10.3748/wjg.v26.i16.1901] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
13 Littlejohn P, Finlay BB. When a pandemic and an epidemic collide: COVID-19, gut microbiota, and the double burden of malnutrition. BMC Med 2021;19:31. [PMID: 33504332 DOI: 10.1186/s12916-021-01910-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hong S, Cha KH, Park JH, Jung DS, Choi JH, Yoo G, Nho CW. Cinnamic acid suppresses bone loss via induction of osteoblast differentiation with alteration of gut microbiota. J Nutr Biochem 2021;:108900. [PMID: 34748919 DOI: 10.1016/j.jnutbio.2021.108900] [Reference Citation Analysis]
15 Inada KOP, Leite IB, Martins ABN, Fialho E, Tomás-Barberán FA, Perrone D, Monteiro M. Jaboticaba berry: A comprehensive review on its polyphenol composition, health effects, metabolism, and the development of food products. Food Res Int 2021;147:110518. [PMID: 34399496 DOI: 10.1016/j.foodres.2021.110518] [Reference Citation Analysis]
16 Chen F, Chen Z, Chen M, Chen G, Huang Q, Yang X, Yin H, Chen L, Zhang W, Lin H, Ou M, Wang L, Chen Y, Lin C, Xu W, Yin G. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients. NPJ Biofilms Microbiomes 2021;7:60. [PMID: 34267209 DOI: 10.1038/s41522-021-00231-6] [Reference Citation Analysis]
17 Huang R, Zhu Z, Wu S, Wang J, Chen M, Liu W, Huang A, Zhang J, Wu Q, Ding Y. Polysaccharides from Cordyceps militaris prevent obesity in association with modulating gut microbiota and metabolites in high-fat diet-fed mice. Food Research International 2022;157:111197. [DOI: 10.1016/j.foodres.2022.111197] [Reference Citation Analysis]
18 Bielka W, Przezak A, Pawlik A. The Role of the Gut Microbiota in the Pathogenesis of Diabetes. Int J Mol Sci 2022;23:480. [PMID: 35008906 DOI: 10.3390/ijms23010480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
19 Park YH, An M, Kim JK, Lim YH. Antiobesity effect of ethanolic extract of Ramulus mori in differentiated 3T3-L1 adipocytes and high-fat diet-induced obese mice. J Ethnopharmacol 2020;251:112542. [PMID: 31904494 DOI: 10.1016/j.jep.2020.112542] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Wu T, Gao Y, Hao J, Geng J, Zhang J, Yin J, Liu R, Sui W, Gong L, Zhang M. Capsanthin extract prevents obesity, reduces serum TMAO levels and modulates the gut microbiota composition in high-fat-diet induced obese C57BL/6J mice. Food Res Int 2020;128:108774. [PMID: 31955744 DOI: 10.1016/j.foodres.2019.108774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ni Y, Ni L, Zhuge F, Fu Z. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease. Mol Nutr Food Res 2020;64:e2000375. [PMID: 32738185 DOI: 10.1002/mnfr.202000375] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Todosenko N, Vulf M, Yurova K, Khaziakhmatova O, Mikhailova L, Litvinova L. Causal Links between Hypovitaminosis D and Dysregulation of the T Cell Connection of Immunity Associated with Obesity and Concomitant Pathologies. Biomedicines 2021;9:1750. [PMID: 34944566 DOI: 10.3390/biomedicines9121750] [Reference Citation Analysis]
23 Vallianou N, Kounatidis D, Christodoulatos GS, Panagopoulos F, Karampela I, Dalamaga M. Mycobiome and Cancer: What Is the Evidence? Cancers (Basel) 2021;13:3149. [PMID: 34202433 DOI: 10.3390/cancers13133149] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Yao H, Fan C, Fan X, Lu Y, Wang Y, Wang R, Tang T, Qi K. Effects of gut microbiota on leptin expression and body weight are lessened by high-fat diet in mice. Br J Nutr 2020;124:396-406. [PMID: 32213218 DOI: 10.1017/S0007114520001117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
25 Recaredo G, Marin-Alejandre BA, Cantero I, Monreal JI, Herrero JI, Benito-Boillos A, Elorz M, Tur JA, Martínez JA, Zulet MA, Abete I. Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study. Nutrients 2019;11:E2359. [PMID: 31623368 DOI: 10.3390/nu11102359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
26 Dalamaga M, Zheng L, Liu J. Gut mycobiome as a promising preventive and therapeutic target for metabolic disorders. Metabolism Open 2022;13:100168. [DOI: 10.1016/j.metop.2022.100168] [Reference Citation Analysis]
27 Sikora M, Stec A, Chrabaszcz M, Knot A, Waskiel-Burnat A, Rakowska A, Olszewska M, Rudnicka L. Gut Microbiome in Psoriasis: An Updated Review. Pathogens 2020;9:E463. [PMID: 32545459 DOI: 10.3390/pathogens9060463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
28 Wang S, Yong H, He XD. Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus. World J Diabetes 2021; 12(7): 1070-1080 [PMID: 34326955 DOI: 10.4239/wjd.v12.i7.1070] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Eslami M, Bahar A, Hemati M, Rasouli Nejad Z, Mehranfar F, Karami S, Kobyliak NM, Yousefi B. Dietary pattern, colonic microbiota and immunometabolism interaction: new frontiers for diabetes mellitus and related disorders. Diabet Med 2021;38:e14415. [PMID: 33025587 DOI: 10.1111/dme.14415] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Zeng Q, Yang Z, Wang F, Li D, Liu Y, Wang D, Zhao X, Li Y, Wang Y, Feng X, Chen J, Li Y, Zheng Y, Kenney T, Gu H, Feng S, Li S, He Y, Xu X, Dai W. Association between metabolic status and gut microbiome in obese populations. Microb Genom 2021;7. [PMID: 34356001 DOI: 10.1099/mgen.0.000639] [Reference Citation Analysis]
31 Han D, Gao P, Li R, Tan P, Xie J, Zhang R, Li J. Multicenter assessment of microbial community profiling using 16S rRNA gene sequencing and shotgun metagenomic sequencing. J Adv Res 2020;26:111-21. [PMID: 33133687 DOI: 10.1016/j.jare.2020.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
32 Wang Z, Zeng M, Wang Z, Qin F, Wang Y, Chen J, Christian M, He Z. Food phenolics stimulate adipocyte browning via regulating gut microecology. Crit Rev Food Sci Nutr 2021;:1-27. [PMID: 34738509 DOI: 10.1080/10408398.2021.1997905] [Reference Citation Analysis]
33 Wei YX, Zheng KY, Wang YG. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity. World J Gastroenterol 2021; 27(33): 5555-5565 [PMID: 34588751 DOI: 10.3748/wjg.v27.i33.5555] [Reference Citation Analysis]
34 du Preez R, Majzoub ME, Thomas T, Panchal SK, Brown L. Nannochloropsis oceanica as a Microalgal Food Intervention in Diet-Induced Metabolic Syndrome in Rats. Nutrients 2021;13:3991. [PMID: 34836248 DOI: 10.3390/nu13113991] [Reference Citation Analysis]
35 Gómez-Zorita S, González-Arceo M, Trepiana J, Eseberri I, Fernández-Quintela A, Milton-Laskibar I, Aguirre L, González M, Portillo MP. Anti-Obesity Effects of Macroalgae. Nutrients 2020;12:E2378. [PMID: 32784488 DOI: 10.3390/nu12082378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
36 Dalamaga M, Christodoulatos GS, Karampela I, Vallianou N, Apovian CM. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Curr Obes Rep 2021. [PMID: 33909265 DOI: 10.1007/s13679-021-00436-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
37 Wang S, Ren H, Zhong H, Zhao X, Li C, Ma J, Gu X, Xue Y, Huang S, Yang J, Chen L, Chen G, Qu S, Liang J, Qin L, Huang Q, Peng Y, Li Q, Wang X, Zou Y, Shi Z, Li X, Li T, Yang H, Lai S, Xu G, Li J, Zhang Y, Gu Y, Wang W. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study. Gut Microbes 2022;14:2003176. [PMID: 34923903 DOI: 10.1080/19490976.2021.2003176] [Reference Citation Analysis]
38 Gawlik-Kotelnicka O, Strzelecki D. Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap. Life (Basel) 2021;11:117. [PMID: 33557031 DOI: 10.3390/life11020117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Wang L, Cheng R, Sun X, Zhao Y, Ge W, Yang Y, Gao Y, Ding Z, Liu J, Zhang J. Preparation and Gut Microbiota Modulatory Property of the Oligosaccharide Riclinoctaose. J Agric Food Chem 2021;69:3667-76. [PMID: 33750134 DOI: 10.1021/acs.jafc.0c07783] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch‐ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, Mcardle HJ, Naska A, Peláez C, Pentieva K, Siani A, Thies F, Tsabouri S, Adan R, Emmett P, Galli C, Kersting M, Moynihan P, Tappy L, Ciccolallo L, de Sesmaisons‐lecarré A, Fabiani L, Horvath Z, Martino L, Muñoz Guajardo I, Valtueña Martínez S, Vinceti M; EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Tolerable upper intake level for dietary sugars. EFS2 2022;20. [DOI: 10.2903/j.efsa.2022.7074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Colak Y, Hasan B, Erkalma B, Tandon K, Zervos X, Menzo EL, Erim T. Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target. Clin Res Hepatol Gastroenterol 2021;45:101710. [PMID: 33930586 DOI: 10.1016/j.clinre.2021.101710] [Reference Citation Analysis]
42 Anderson KM, Ferranti EP, Alagha EC, Mykityshyn E, French CE, Reilly CM. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure. Heart Fail Rev 2022. [PMID: 35726110 DOI: 10.1007/s10741-022-10254-6] [Reference Citation Analysis]
43 Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 2021;11:625913. [PMID: 33816335 DOI: 10.3389/fcimb.2021.625913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 Ortega-Hernández A, Martínez-Martínez E, Gómez-Gordo R, López-Andrés N, Fernández-Celis A, Gutiérrrez-Miranda B, Nieto ML, Alarcón T, Alba C, Gómez-Garre D, Cachofeiro V. The Interaction between Mitochondrial Oxidative Stress and Gut Microbiota in the Cardiometabolic Consequences in Diet-Induced Obese Rats. Antioxidants (Basel) 2020;9:E640. [PMID: 32708095 DOI: 10.3390/antiox9070640] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
45 Cunningham AL, Stephens JW, Harris DA. A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids Health Dis 2021;20:65. [PMID: 34233682 DOI: 10.1186/s12944-021-01491-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 S A, K G, A AM. Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19. J Biomol Struct Dyn 2021;:1-17. [PMID: 34699326 DOI: 10.1080/07391102.2021.1994875] [Reference Citation Analysis]
47 Tsigalou C, Vallianou N, Dalamaga M. Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity? Curr Obes Rep 2020;9:245-54. [PMID: 32632847 DOI: 10.1007/s13679-020-00397-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
48 Donato L, Alibrandi S, Scimone C, Castagnetti A, Rao G, Sidoti A, D'Angelo R. Gut-Brain Axis Cross-Talk and Limbic Disorders as Biological Basis of Secondary TMAU. J Pers Med 2021;11:87. [PMID: 33572540 DOI: 10.3390/jpm11020087] [Reference Citation Analysis]
49 Hasani A, Ebrahimzadeh S, Hemmati F, Khabbaz A, Hasani A, Gholizadeh P. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J Med Microbiol 2021;70. [PMID: 34623232 DOI: 10.1099/jmm.0.001435] [Reference Citation Analysis]
50 du Preez R, Magnusson M, Majzoub ME, Thomas T, Praeger C, Glasson CRK, Panchal SK, Brown L. Brown Seaweed Sargassum siliquosum as an Intervention for Diet-Induced Obesity in Male Wistar Rats. Nutrients 2021;13:1754. [PMID: 34064139 DOI: 10.3390/nu13061754] [Reference Citation Analysis]
51 Sundaram S, Borthakur A. Altered intestinal epithelial nutrient transport: an underappreciated factor in obesity modulated by diet and microbiota. Biochem J 2021;478:975-95. [PMID: 33661278 DOI: 10.1042/BCJ20200902] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Aguirre García MM, Mancilla-galindo J, Paredes-paredes M, Tiburcio ÁZ, Ávila-vanzzini N. Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome. Future Virology 2021;16:43-57. [DOI: 10.2217/fvl-2020-0310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
53 Karampela I, Chrysanthopoulou E, Christodoulatos GS, Dalamaga M. Is There an Obesity Paradox in Critical Illness? Epidemiologic and Metabolic Considerations. Curr Obes Rep 2020;9:231-44. [DOI: 10.1007/s13679-020-00394-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
54 Peluzio MDCG, Martinez JA, Milagro FI. Postbiotics: Metabolites and mechanisms involved in microbiota-host interactions. Trends in Food Science & Technology 2021;108:11-26. [DOI: 10.1016/j.tifs.2020.12.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 16.0] [Reference Citation Analysis]
55 Ma H, Li X, Yang H, Qiu Y, Xiao W. The Pathology and Physiology of Ileostomy. Front Nutr 2022;9:842198. [DOI: 10.3389/fnut.2022.842198] [Reference Citation Analysis]
56 Gabel K, Marcell J, Cares K, Kalam F, Cienfuegos S, Ezpeleta M, Varady KA. Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study. Nutr Health 2020;26:79-85. [PMID: 32228124 DOI: 10.1177/0260106020910907] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
57 Chen J, Pi X, Liu W, Ding Q, Wang X, Jia W, Zhu L. Age-related changes of microbiota in midlife associated with reduced saccharolytic potential: an in vitro study. BMC Microbiol 2021;21:47. [PMID: 33588748 DOI: 10.1186/s12866-021-02103-7] [Reference Citation Analysis]
58 Vallianou N, Dalamaga M, Stratigou T, Karampela I, Tsigalou C. Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence. Curr Obes Rep 2021. [PMID: 33945146 DOI: 10.1007/s13679-021-00438-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Álvarez-Cilleros D, Ramos S, López-Oliva ME, Escrivá F, Álvarez C, Fernández-Millán E, Martín MÁ. Cocoa diet modulates gut microbiota composition and improves intestinal health in Zucker diabetic rats. Food Res Int 2020;132:109058. [PMID: 32331673 DOI: 10.1016/j.foodres.2020.109058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
60 Wang L, Zhang P, Li C, Xu F, Chen J. A polysaccharide from Rosa roxburghii Tratt fruit attenuates high-fat diet-induced intestinal barrier dysfunction and inflammation in mice by modulating the gut microbiota. Food Funct 2021. [PMID: 34932054 DOI: 10.1039/d1fo03190b] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
61 Wang M, Li L, Chen Y, Lian G, Wang J, Zhang J, Shan K, Shang L, Tian F, Jing C. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery. Obes Surg 2021;31:327-36. [PMID: 32974816 DOI: 10.1007/s11695-020-04974-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Dalamaga M, Muscogiuri G, Paganitsa G, Parvouleskou G, Syriou V, Karagkoynis P, Stratigou T, Vallianou N, Christodoulatos GS, Karampela I, Daskalopoulou K. Adherence to the Mediterranean diet is an independent predictor of circulating vitamin D levels in normal weight and non-smoker adults: an observational cross-sectional study. Int J Food Sci Nutr 2021;72:848-60. [PMID: 33509003 DOI: 10.1080/09637486.2021.1878488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
63 Zhu LB, Zhang YC, Huang HH, Lin J. Prospects for clinical applications of butyrate-producing bacteria. World J Clin Pediatr 2021; 10(5): 84-92 [PMID: 34616650 DOI: 10.5409/wjcp.v10.i5.84] [Reference Citation Analysis]
64 Nogacka AM, de Los Reyes-Gavilán CG, Martínez-Faedo C, Ruas-Madiedo P, Suarez A, Mancabelli L, Ventura M, Cifuentes A, León C, Gueimonde M, Salazar N. Impact of Extreme Obesity and Diet-Induced Weight Loss on the Fecal Metabolome and Gut Microbiota. Mol Nutr Food Res 2021;65:e2000030. [PMID: 32966685 DOI: 10.1002/mnfr.202000030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Shi Q, Dai L, Zhao Q, Zhang X. A review on the effect of gut microbiota on metabolic diseases. Arch Microbiol 2022;204:192. [PMID: 35195774 DOI: 10.1007/s00203-022-02802-3] [Reference Citation Analysis]
66 Verma A, Nelson MT, DePaolo WR, Hampe C, Roth CL. A randomized double-blind placebo controlled pilot study of probiotics in adolescents with severe obesity. J Diabetes Metab Disord 2021;20:1289-300. [PMID: 34900780 DOI: 10.1007/s40200-021-00855-7] [Reference Citation Analysis]
67 López-Moreno A, Suárez A, Avanzi C, Monteoliva-Sánchez M, Aguilera M. Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis. Nutrients 2020;12:E1921. [PMID: 32610476 DOI: 10.3390/nu12071921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
68 Nogacka AM, de Los Reyes-Gavilán CG, Arboleya S, Ruas-Madiedo P, Martínez-Faedo C, Suarez A, He F, Harata G, Endo A, Salazar N, Gueimonde M. In vitro Selection of Probiotics for Microbiota Modulation in Normal-Weight and Severely Obese Individuals: Focus on Gas Production and Interaction With Intestinal Epithelial Cells. Front Microbiol 2021;12:630572. [PMID: 33633711 DOI: 10.3389/fmicb.2021.630572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Neyrinck AM, Rodriguez J, Zhang Z, Seethaler B, Sánchez CR, Roumain M, Hiel S, Bindels LB, Cani PD, Paquot N, Cnop M, Nazare JA, Laville M, Muccioli GG, Bischoff SC, Walter J, Thissen JP, Delzenne NM. Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial. Eur J Nutr 2021;60:3159-70. [PMID: 33544206 DOI: 10.1007/s00394-021-02484-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
70 Jing N, Liu X, Jin M, Yang X, Hu X, Li C, Zhao K. Fubrick tea attenuates high-fat diet induced fat deposition and metabolic disorder by regulating gut microbiota and caffeine metabolism. Food Funct 2020;11:6971-86. [PMID: 32697259 DOI: 10.1039/d0fo01282c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
71 du Preez R, Pahl J, Arora M, Ravi Kumar MNV, Brown L, Panchal SK. Low-Dose Curcumin Nanoparticles Normalise Blood Pressure in Male Wistar Rats with Diet-Induced Metabolic Syndrome. Nutrients 2019;11:E1542. [PMID: 31288419 DOI: 10.3390/nu11071542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
72 Llévenes P, Rodrigues-Díez R, Cros-Brunsó L, Prieto MI, Casaní L, Balfagón G, Blanco-Rivero J. Beneficial Effect of a Multistrain Synbiotic Prodefen® Plus on the Systemic and Vascular Alterations Associated with Metabolic Syndrome in Rats: The Role of the Neuronal Nitric Oxide Synthase and Protein Kinase A. Nutrients 2020;12:E117. [PMID: 31906276 DOI: 10.3390/nu12010117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
73 Wilkins AT, Reimer RA. Obesity, Early Life Gut Microbiota, and Antibiotics. Microorganisms 2021;9:413. [PMID: 33671180 DOI: 10.3390/microorganisms9020413] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
74 Vallianou N, Stratigou T, Christodoulatos GS, Tsigalou C, Dalamaga M. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives. Curr Obes Rep 2020;9:179-92. [PMID: 32472285 DOI: 10.1007/s13679-020-00379-w] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 23.0] [Reference Citation Analysis]
75 Fotis D, Liu J, Dalamaga M. Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives. Metabolism Open 2022;14:100178. [DOI: 10.1016/j.metop.2022.100178] [Reference Citation Analysis]
76 Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front Immunol 2021;12:578386. [PMID: 33717063 DOI: 10.3389/fimmu.2021.578386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
77 Maliakkal BJ. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation. Transl Gastroenterol Hepatol 2020;5:36. [PMID: 32632387 DOI: 10.21037/tgh.2019.12.02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Tsigalou C, Paraschaki A, Karvelas A, Kantartzi K, Gagali K, Tsairidis D, Bezirtzoglou E. Gut microbiome and Mediterranean diet in the context of obesity. Current knowledge, perspectives and potential therapeutic targets. Metabol Open 2021;9:100081. [PMID: 33644741 DOI: 10.1016/j.metop.2021.100081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
79 Lemons JMS, Liu L. Chewing the Fat with Microbes: Lipid Crosstalk in the Gut. Nutrients 2022;14:573. [DOI: 10.3390/nu14030573] [Reference Citation Analysis]
80 Monaghan TM, Biswas RN, Nashine RR, Joshi SS, Mullish BH, Seekatz AM, Blanco JM, McDonald JAK, Marchesi JR, Yau TO, Christodoulou N, Hatziapostolou M, Pucic-Bakovic M, Vuckovic F, Klicek F, Lauc G, Xue N, Dottorini T, Ambalkar S, Satav A, Polytarchou C, Acharjee A, Kashyap RS. Multiomics Profiling Reveals Signatures of Dysmetabolism in Urban Populations in Central India. Microorganisms 2021;9:1485. [PMID: 34361920 DOI: 10.3390/microorganisms9071485] [Reference Citation Analysis]
81 Chen J, Hall S, Vitetta L. Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Rev Med Virol 2021;31:1-13. [PMID: 34546607 DOI: 10.1002/rmv.2211] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]
82 Keady MM, Prado N, Lim HC, Brown J, Paris S, Muletz-Wolz CR. Clinical health issues, reproductive hormones, and metabolic hormones associated with gut microbiome structure in African and Asian elephants. Anim Microbiome 2021;3:85. [PMID: 34930501 DOI: 10.1186/s42523-021-00146-9] [Reference Citation Analysis]
83 Khanna S, Bishnoi M, Kondepudi KK, Shukla G. Synbiotic (Lactiplantibacillus pentosus GSSK2 and isomalto-oligosaccharides) supplementation modulates pathophysiology and gut dysbiosis in experimental metabolic syndrome. Sci Rep 2021;11:21397. [PMID: 34725349 DOI: 10.1038/s41598-021-00601-2] [Reference Citation Analysis]
84 Thye AY, Bah Y, Law JW, Tan LT, He Y, Wong S, Thurairajasingam S, Chan K, Lee L, Letchumanan V. Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines 2022;10:1037. [DOI: 10.3390/biomedicines10051037] [Reference Citation Analysis]
85 Gutiérrez-Repiso C, Moreno-Indias I, Tinahones FJ. Shifts in gut microbiota and their metabolites induced by bariatric surgery. Impact of factors shaping gut microbiota on bariatric surgery outcomes. Rev Endocr Metab Disord 2021. [PMID: 34287758 DOI: 10.1007/s11154-021-09676-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Hsu CN, Hou CY, Chang-Chien GP, Lin S, Tain YL. Maternal Garlic Oil Supplementation Prevents High-Fat Diet-Induced Hypertension in Adult Rat Offspring: Implications of H2S-Generating Pathway in the Gut and Kidneys. Mol Nutr Food Res 2021;65:e2001116. [PMID: 33547712 DOI: 10.1002/mnfr.202001116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
87 Vallianou N, Christodoulatos GS, Karampela I, Tsilingiris D, Magkos F, Stratigou T, Kounatidis D, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2022;12:56. [DOI: 10.3390/biom12010056] [Reference Citation Analysis]
88 Croce S, Avanzini MA, Regalbuto C, Cordaro E, Vinci F, Zuccotti G, Calcaterra V. Adipose Tissue Immunomodulation and Treg/Th17 Imbalance in the Impaired Glucose Metabolism of Children with Obesity. Children (Basel) 2021;8:554. [PMID: 34199040 DOI: 10.3390/children8070554] [Reference Citation Analysis]
89 Nandy D, Craig SJC, Cai J, Tian Y, Paul IM, Savage JS, Marini ME, Hohman EE, Reimherr ML, Patterson AD, Makova KD, Chiaromonte F. Metabolomic profiling of stool of two-year old children from the INSIGHT study reveals links between butyrate and child weight outcomes. Pediatr Obes 2021;:e12833. [PMID: 34327846 DOI: 10.1111/ijpo.12833] [Reference Citation Analysis]
90 Ramne S, Brunkwall L, Ericson U, Gray N, Kuhnle GGC, Nilsson PM, Orho-Melander M, Sonestedt E. Gut microbiota composition in relation to intake of added sugar, sugar-sweetened beverages and artificially sweetened beverages in the Malmö Offspring Study. Eur J Nutr 2021;60:2087-97. [PMID: 33030577 DOI: 10.1007/s00394-020-02392-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]